Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 26 Sept 2025
- Closes
- 7 Jun 2028, 23:59 UTC
- Reference
- PAR-25-449
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and other brain and/or body based interventions) impact mechanisms of emotional well-being (EWB) and their associations with whole person health (WPH), consistent with the NIH priority to address the health needs of the American people and improve their well-being. The NOFO will support rigorous and well-powered mechanistic research studies that are supported by strong preliminary data. The studies should examine the effects of mind and body interventions on innovative mechanisms of EWB (as the primary outcome), as well as the associated relationship with the Whole Person Health Index (WPHI, as a secondary outcome). To enhance research safety, rigor, and efficiency of NIH-funded mechanistic clinical trials, this initiative will use a two-phased award funding mechanism (R61/R33). The funding will support an initial phase (R61) to establish feasibility benchmarks for the proposed mechanistic clinical trial(s), followed by a second phase (R33) to complete the full-scale trials, which will be contingent upon successful completion of R61 milestones. Applications should provide preliminary data that are comparable in quality and quantity to those expected for an R01 proposal. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
CFDA number(s): 93.213
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 378 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 369 open Healthcare & Pharma tenders in United States. This one closes in 618 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)· closes 17 Apr
Similar Healthcare & Pharma tenders
- Bag, Medical Instrument — 25 each, NSN 6545016918890· closes 5 Oct
- Scanner, Acquisition, TH — 1 each, NSN 6520017024522· closes 5 Oct
- Ventilator, Volume, Port — 6 each, NSN 6515017029684· closes 5 Oct
- Comprehensive Medical Services -FDC Houston — General Health Care Services· closes 17 Nov
- 2027 Southern Hemisphere Influenza Vaccine — Drugs and Biologicals· closes 14 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- 西安交通大学医学院第一附属医院心理量表评估系统(心理ct)采购项目公开招标公告西安交通大学第一附属医院 · China
- 108 VideomanagementStädtisches Krankenhaus Kiel GmbH · Germany
- LOS 3 - 1.600 EA Katheter, arterielle Embolektomie, 5FBundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr · Germany
- arbeitsmedizinische Betreuung für die Kreisverwaltung CoesfeldKreis Coesfeld · Germany
- DFG Großgerät Koordinatenmessgerät mit Tomografieeinrichtung - Mikrofocus- ComputertomografRheinland-Pfälzische Technische Universität Kaiserslautern-Landau · Germany
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →